Comparison of Efficacies of Commonly Used Hypertension Treatment Modalities: A Retrospective Study of 1900 Participants in a Hypertension Clinic

医学 血压 联合疗法 回顾性队列研究 内科学 药物治疗
作者
Xiexiong Zhao,Anu Dahal,Qiong Yang,Yan Yang,Zewen Ding,Junwen Wang,Joel Swai,Weihong Jiang,Yong Li
出处
期刊:Medical Science Monitor [International Scientific Information, Inc.]
卷期号:26 被引量:2
标识
DOI:10.12659/msm.921211
摘要

BACKGROUND:Although various antihypertensive medications are available, some hypertensive patients have uncontrolled blood pressures, especially in the clinic. The aim of the present study was to compare the efficacies of various antihypertensive therapies in our hypertension (HTN) clinic (monotherapy vs. combination therapy, fixed-dose combination (FDC) versus free equivalent combination (FEC), and diuretics versus non-diuretics. MATERIAL AND METHODS:In this retrospective study, patients at the HTN clinic of the Third Xiangya Hospital with primary hypertension were enrolled from June 2016 to February 2017. Data on participants’ basic characteristics, blood pressure data, and treatment modalities were collected. The proportions of participants attaining target blood pressure after treatment with antihypertensive modalities were calculated and compared. RESULTS:Among 1900 participants, combination therapy had a better control efficacy than monotherapy (P<0.0005). When HTN was treated by 2 kinds of drugs, FEC was used much more frequently than FDC (P<0.0005). In grade 3 HTN, FDC had a higher control rate (P=0.002). If more than 2 kinds of drugs were used, FDC+OTHER had a slightly higher control rate in grade 2 and 3 (42.1% vs. 38.5%, P=0.724; 36.2% vs. 31.0%, P=0.526, respectively). Therapies with diuretics had better control rates than those without diuretics (43.1% vs. 36.9%, P=0.025). CONCLUSIONS:In our clinic, FEC was prescribed more often than FDC. When blood pressure is significantly elevated, especially at levels 2 or 3, FDC seems to have a better control rate than FEC. Therapies with diuretics controlled HTN more efficiently.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
远航完成签到 ,获得积分10
刚刚
刚刚
彭于晏应助Rrr采纳,获得10
刚刚
卓然发布了新的文献求助10
刚刚
精明的中蓝完成签到,获得积分10
1秒前
66应助小钻风采纳,获得10
1秒前
1秒前
领导范儿应助星星采纳,获得10
2秒前
汉堡包应助shotgod采纳,获得10
2秒前
如寄完成签到 ,获得积分10
2秒前
顾闭月发布了新的文献求助10
3秒前
研友_VZG7GZ应助石头采纳,获得10
3秒前
有益发布了新的文献求助10
4秒前
xibei完成签到 ,获得积分10
4秒前
5秒前
丘比特应助爱吃肉的猪采纳,获得10
5秒前
5秒前
5秒前
dyh6802发布了新的文献求助10
5秒前
6秒前
Wxx完成签到 ,获得积分10
6秒前
七栀完成签到,获得积分10
6秒前
科研通AI2S应助阿芙乐尔采纳,获得10
8秒前
一条贤与完成签到,获得积分20
8秒前
9秒前
9秒前
yl完成签到,获得积分10
9秒前
泊声完成签到,获得积分20
10秒前
su发布了新的文献求助10
10秒前
Island发布了新的文献求助10
10秒前
科研小民工应助一枪入魂采纳,获得30
10秒前
11秒前
11秒前
科研通AI2S应助gwh采纳,获得10
12秒前
12秒前
12秒前
12秒前
隐形曼青应助zhihan采纳,获得10
14秒前
14秒前
xylxyl完成签到,获得积分10
14秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527849
求助须知:如何正确求助?哪些是违规求助? 3107938
关于积分的说明 9287239
捐赠科研通 2805706
什么是DOI,文献DOI怎么找? 1540033
邀请新用户注册赠送积分活动 716893
科研通“疑难数据库(出版商)”最低求助积分说明 709794